Variant report
Variant | nsv523717 |
---|---|
Chromosome Location | chr2:171719565-171722926 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:171721677..171726010-chr2:171731476..171734906,5 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4439928 | chr2:171719565-171719566 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs533514048 | chr2:171719584-171719585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548258243 | chr2:171719602-171719603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12472230 | chr2:171719628-171719629 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs367662136 | chr2:171719654-171719655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75443830 | chr2:171719678-171719679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549432884 | chr2:171719696-171719697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567903734 | chr2:171719700-171719701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201081419 | chr2:171719708-171719709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558814799 | chr2:171719709-171719710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77999238 | chr2:171719743-171719744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142681058 | chr2:171719765-171719766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565331687 | chr2:171719766-171719767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571416850 | chr2:171719768-171719769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534851609 | chr2:171719805-171719806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551440070 | chr2:171719817-171719818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs117210665 | chr2:171719831-171719832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10930443 | chr2:171719836-171719837 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs189784988 | chr2:171719847-171719848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35072833 | chr2:171719859-171719860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547073555 | chr2:171719887-171719888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181401455 | chr2:171719921-171719922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184605424 | chr2:171719964-171719965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78955730 | chr2:171719966-171719967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189542944 | chr2:171719969-171719970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76876738 | chr2:171720013-171720014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs180760446 | chr2:171720047-171720048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543167098 | chr2:171720064-171720065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561315994 | chr2:171720132-171720133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146433792 | chr2:171720163-171720164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546866227 | chr2:171720180-171720181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139802127 | chr2:171720207-171720208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73025207 | chr2:171720224-171720225 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs376434624 | chr2:171720274-171720275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535867882 | chr2:171720313-171720314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553177786 | chr2:171720407-171720408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112364931 | chr2:171720413-171720414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536861266 | chr2:171720439-171720440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549208960 | chr2:171720577-171720578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567449087 | chr2:171720597-171720598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13406480 | chr2:171720620-171720621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553273311 | chr2:171720623-171720624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs578086395 | chr2:171720645-171720646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563537640 | chr2:171720669-171720670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146317519 | chr2:171720671-171720672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs74603477 | chr2:171720673-171720674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370853917 | chr2:171720682-171720683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571542510 | chr2:171720729-171720730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574522771 | chr2:171720787-171720788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186396646 | chr2:171720849-171720850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Prostate cancer | 16573809 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Donnai-Barrow syndrome | 21085971 | CNVD |
Breast cancer | 21045282 | CNVD |
Limb abnormalities | 22140379 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:171699000-171730000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:171705200-171725200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr2:171710400-171725600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr2:171713800-171724000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr2:171717000-171729400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr2:171718200-171719600 | Enhancers | K562 | blood |
7 | chr2:171718200-171729400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr2:171718400-171729200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr2:171718600-171729400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
10 | chr2:171718600-171729600 | Weak transcription | Right Atrium | heart |
11 | chr2:171719400-171720400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
12 | chr2:171720400-171720600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |